2
results found
Non-small cell lung cancer (NSCLC) patients carrying HER2 20ins exon 20 insertion (HER2 20ins) are poorly respond to conventional therapies and pan HER inhibitors. Trastuzumab Deruxtecan (T-DXd) has b...
HER2 (ERBB2)
NSCLC
Deruxtecan (T-DXd
DS-8201)
Genomic instability
Immune microenvironment
Background: Accurately predicting treatment outcomes in patients with advanced non-small cell lung cancer (NSCLC) remains a significant clinical challenge. While circulating tumor DNA (ctDNA) within p...
Liquid biopsy monitoring
Cell-free DNA
Non-small cell lung cancer
Progression-free survival
Copy-number alterations
cfDNA fragmentation
Low-coverage whole-genome sequencing
SinoXiv